{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:50:37Z","timestamp":1791654637370,"version":"4.3.4"},"reference-count":177,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbi.2026.106931","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:05:43Z","timestamp":1785539143000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuroimmune crosstalk in HIV-associated neurocognitive disorders and the impact of antiretroviral therapy"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-6396","authenticated-orcid":false,"given":"George Chigozie","family":"Njoku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Etafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukamaka Obiamaka","family":"Modebelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Yarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106931_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13365-013-0227-1","article-title":"Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system","volume":"20","author":"Akay","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/viro.1996.0108","article-title":"HIV-1 infection of cultured human adult oligodendrocytes","volume":"217","author":"Albright","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.bbi.2026.106931_b0020","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s13365-020-00870-z","article-title":"Lifetime antiretroviral exposure and neurocognitive impairment in HIV","volume":"26","author":"Amusan","year":"2020","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0025","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/jac\/dkv183","article-title":"Efavirenz and the CNS: what we already know and questions that need to be answered","volume":"70","author":"Apostolova","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbi.2026.106931_b0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/135965350801300203","article-title":"The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the delta trial","volume":"13","author":"Arenas-Pinto","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbi.2026.106931_b0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/neuroglia6010014","article-title":"Tryptophan metabolism through the kynurenine pathway in glial cells","volume":"6","author":"Argolo","year":"2025","journal-title":"Neuroglia"},{"key":"10.1016\/j.bbi.2026.106931_b0040","first-page":"522","article-title":"Severe efavirenz associated neurotoxicity: a retrospective cohort study","volume":"38","author":"Arnab","year":"2023","journal-title":"S. Afr. J. Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","article-title":"Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain","volume":"14","author":"Asahchop","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.bbi.2026.106931_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00212","article-title":"Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update","volume":"9","author":"Atluri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0055","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/cells11101599","article-title":"Recent advances in the molecular and cellular mechanisms of gp120-mediated neurotoxicity","volume":"11","author":"Avdoshina","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0060","doi-asserted-by":"crossref","first-page":"44714","DOI":"10.1074\/jbc.M112.397158","article-title":"Multiple NF-\u03baB Sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance","volume":"287","author":"Bachu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2026.106931_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12981-023-00511-5","article-title":"Role of microglia in HIV-1 infection","volume":"20","author":"Bai","year":"2023","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.bbi.2026.106931_b0070","article-title":"The penetration of therapeutics across the blood-brain barrier: classic case studies and clinical implications","volume":"5","author":"Banks","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbi.2026.106931_b0075","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<946::AID-JNR5>3.0.CO;2-D","article-title":"HIV-gp120 affects the functional activity of oligodendrocytes and their susceptibility to complement","volume":"50","author":"Bernardo","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11481-019-09858-x","article-title":"Cerebral vascular toxicity of antiretroviral therapy","volume":"16","author":"Bertrand","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0085","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/QAD.0000000000004308","article-title":"The HIV\/AIDS pandemic: where are we now?","volume":"39","author":"Beyrer","year":"2025","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1750-3639.2004.tb00503.x","article-title":"Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected\/affected cell populations","volume":"14","author":"Bissel","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbi.2026.106931_b0095","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3390\/biomedicines9080925","article-title":"Microglia: the real foe in HIV-1-associated neurocognitive disorders?","volume":"9","author":"Borrajo L\u00f3pez","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbi.2026.106931_b0100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/glia.23642","article-title":"HIV-1 tat promotes astrocytic release of CCL2 through MMP\/PAR-1 signaling","volume":"67","author":"Bozzelli","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2026.106931_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrn3710","article-title":"Microglial phagocytosis of live neurons","volume":"15","author":"Brown","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1553594","article-title":"Nef is a key player in neuroinflammation and myelin impairment associated with HAND","volume":"16","author":"Bukrinsky","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2026.106931_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S1355617719000985","article-title":"Use of neuroimaging to inform optimal neurocognitive criteria for detecting HIV-associated brain abnormalities","volume":"26","author":"Campbell","year":"2020","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.bbi.2026.106931_b0120","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1111\/ejn.16427","article-title":"Short-term exposure to HIV Tat induces glial activation and changes in perineuronal nets","volume":"60","author":"Carey","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11904-022-00605-1","article-title":"HIV compartmentalization in the CNS and its impact in treatment outcomes and cure strategies","volume":"19","author":"Chan","year":"2022","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1621338","article-title":"HIV-Tat and vascular endothelium: implications in the HIV associated brain, heart, and lung complications","volume":"16","author":"Chandran","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106931_b0135","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/cells14231904","article-title":"Antiretroviral drugs impact autophagy differently in primary human astrocytes","volume":"14","author":"Cheney","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0140","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1523\/JNEUROSCI.3045-16.2017","article-title":"HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation","volume":"37","author":"Chivero","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0145","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/03007995.2026.2651786","article-title":"Long-term outcomes of switching to BIC\/FTC\/TAF with or without prior INSTI experience: real-life data from a monocentric cohort of ART-experienced people with HIV","volume":"42","author":"Cianciaruso","year":"2026","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.bbi.2026.106931_b0150","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2026.106931_b0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12987-023-00507-3","article-title":"Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier","volume":"21","author":"Col\u00f3n Ortiz","year":"2024","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.bbi.2026.106931_b0160","first-page":"488","article-title":"Central nervous system and neuropsychiatric disturbances in people living with HIV","volume":"31","author":"Corti","year":"2023","journal-title":"Infez. Med."},{"key":"10.1016\/j.bbi.2026.106931_b0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3390\/metabo12121202","article-title":"Dolutegravir discontinuation for neuropsychiatric symptoms in people living with HIV and their outcomes after treatment change: a pharmacogenetic study","volume":"12","author":"Cusato","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.bbi.2026.106931_b0170","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jnr.20486","article-title":"NeuroAIDS: contributions of the human immunodeficiency virus\u20101 proteins tat and gp120 as well as CD40 to microglial activation","volume":"81","author":"D\u2019Aversa","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0175","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1038\/s41598-017-07570-5","article-title":"Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging","volume":"7","author":"Dickens","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0180","doi-asserted-by":"crossref","first-page":"15209","DOI":"10.1038\/s41598-020-72214-0","article-title":"Modeling HIV-1 neuropathogenesis using three-dimensional human brain organoids (hBORGs) with HIV-1 infected microglia","volume":"10","author":"Dos Reis","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.31083\/j.jin2309172","article-title":"Human immunodeficiency virus (HIV-1) targets astrocytes via cell-free and cell-associated infection","volume":"23","author":"Dos Reis","year":"2024","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1570162X12666140526123119","article-title":"HIV-1 tat disrupts CX3CL1-CX3CR1 axis in microglia via the NF-\u03baBYY1 pathway","volume":"12","author":"Duan","year":"2014","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.bbi.2026.106931_b0200","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/00002030-199109000-00003","article-title":"Fate of oligodendrocytes in HIV-1 infection","volume":"5","author":"Esiri","year":"1991","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0205","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1523\/JNEUROSCI.3863-05.2006","article-title":"CCL2\/Monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood\u2013brain barrier: a potential mechanism of HIV\u2013CNS invasion and NeuroAIDS","volume":"26","author":"Eugenin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0210","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s13365-012-0119-9","article-title":"HIV peripheral neuropathy progression: protection with glucose-lowering drugs?","volume":"18","author":"Evans","year":"2012","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2015.11.015","article-title":"HIV alters neuronal mitochondrial fission\/fusion in the brain during HIV-associated neurocognitive disorders","volume":"86","author":"Fields","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0220","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1093\/nar\/gkr1224","article-title":"Human immunodeficiency virus-1 Tat activates NF-\u03baB via physical interaction with I\u03baB-\u03b1 and p65","volume":"40","author":"Fiume","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbi.2026.106931_b0225","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.virs.2025.10.003","article-title":"Efficacy and safety of switching from lopinavir\/ritonavir-based regimens to bictegravir\/emtricitabine\/tenofovir alafenamide in people living with HIV: a multicenter retrospective study","volume":"40","author":"Fu","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.bbi.2026.106931_b0230","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/infdis\/jiu273","article-title":"Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz","volume":"210","author":"Funes","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12026-010-8170-1","article-title":"Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response","volume":"48","author":"Furler","year":"2010","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072503","article-title":"HIV gp120 protein increases the function of connexin 43 hemichannels and pannexin-1 channels in astrocytes: repercussions on astroglial function","volume":"21","author":"Gajardo-Gomez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0245","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s40121-023-00879-x","article-title":"Bictegravir\/emtricitabine\/tenofovir alafenamide versus dolutegravir plus lamivudine for switch therapy in patients with HIV-1 infection: a real-world cohort study","volume":"12","author":"Gan","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.bbi.2026.106931_b0250","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dkr427","article-title":"CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study","volume":"67","author":"Garvey","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbi.2026.106931_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639378","article-title":"Physiologically relevant concentrations of dolutegravir, emtricitabine, and efavirenz induce distinct metabolic alterations in hela epithelial and BV2 microglial cells","volume":"12","author":"George","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106931_b0260","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pharmaceutics12010020","article-title":"ABC transporters at the blood\u2013brain interfaces, their study models, and drug delivery implications in gliomas","volume":"12","author":"Gomez-Zepeda","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbi.2026.106931_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062196","article-title":"The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes","volume":"8","author":"Gray","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106931_b0270","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12974-018-1160-2","article-title":"Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury","volume":"15","author":"Guha","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106931_b0275","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1742-4658.2012.08493.x","article-title":"Quinolinic acid: neurotoxicity","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.bbi.2026.106931_b0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF03033781","article-title":"Involvement of quinolinic acid in AIDS dementia complex","volume":"7","author":"Guillemin","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/v14040829","article-title":"Characterization of HIV-1 infection in microglia-containing human cerebral organoids","volume":"14","author":"Gumbs","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bbi.2026.106931_b0290","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s13365-024-01207-w","article-title":"Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells","volume":"30","author":"Gumbs","year":"2024","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2012.04.010","article-title":"Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance","volume":"95","author":"Gupta","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2026.106931_b0300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20180200","article-title":"Astrocytes and microglia: models and tools","volume":"216","author":"Guttenplan","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2026.106931_b0305","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/glia.20746","article-title":"HIV\u20101 Tat and morphine have interactive effects on oligodendrocyte survival and morphology","volume":"57","author":"Hauser","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2026.106931_b0310","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/sj.jcbfm.9600254","article-title":"HIV-TAT Protein Upregulates Expression of Multidrug Resistance Protein 1 in the Blood\u2013Brain Barrier","volume":"26","author":"Hayashi","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbi.2026.106931_b0315","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1471-4159.2005.03114.x","article-title":"HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells","volume":"93","author":"Hayashi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2026.106931_b0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s13365-025-01270-x","article-title":"Changes in cerebral function parameters in persons with HIV with symptoms of insomnia switching from dolutegravir- to bictegravir-based antiretroviral therapy","volume":"31","author":"Henderson","year":"2025","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.646447","article-title":"The Interplay of HIV-1 and Macrophages in Viral Persistence","volume":"12","author":"Hendricks","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbi.2026.106931_b0330","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jare.2024.01.006","article-title":"Current perspectives on microglia-neuron communication in the central nervous system: Direct and indirect modes of interaction","volume":"66","author":"Hu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0335","article-title":"Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0340","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402677RR","article-title":"Dolutegravir induces endoplasmic reticulum stress at the blood\u2013brain barrier","volume":"39","author":"Huang","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2026.106931_b0345","first-page":"1155","article-title":"Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation","volume":"15","author":"Huang","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0350","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1523\/JNEUROSCI.2051-11.2011","article-title":"Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders","volume":"31","author":"Huang","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0355","doi-asserted-by":"crossref","unstructured":"Hung, K.-M., Chen, P.-C., Hsieh, H.-C., Calkins, M.J., 2017. Mitochondrial defects arise from nucleoside\/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863, 406\u2013413. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.017.","DOI":"10.1016\/j.bbadis.2016.11.017"},{"key":"10.1016\/j.bbi.2026.106931_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/1267041","article-title":"HIV-Associated Neurotoxicity: the Interplay of host and Viral Proteins","volume":"2021","author":"Jadhav","year":"2021","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2026.106931_b0365","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1007\/s43440-023-00515-y","article-title":"Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies","volume":"75","author":"Jakimiuk","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012446","article-title":"HIV transcription persists in the brain of virally suppressed people with HIV","volume":"20","author":"Jamal Eddine","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbi.2026.106931_b0375","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/COH.0000000000000923","article-title":"Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches","volume":"20","author":"Jia","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0380","first-page":"302","article-title":"HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: a potential new treatment target for HAND","volume":"4","author":"Jin","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0385","doi-asserted-by":"crossref","first-page":"133","DOI":"10.20517\/evcna.2022.14","article-title":"HIV-1 Tat induced microglial EVs leads to neuronal synaptodendritic injury: microglia-neuron cross-talk in HAND","volume":"3","author":"Kannan","year":"2022","journal-title":"Extracell Vesicles Circ Nucl Acids"},{"key":"10.1016\/j.bbi.2026.106931_b0390","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1016\/S2352-3018(16)30091-1","article-title":"Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis","volume":"3","author":"Kanters","year":"2016","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.bbi.2026.106931_b0395","doi-asserted-by":"crossref","first-page":"12242","DOI":"10.3390\/ijms241512242","article-title":"Contemporary antiretroviral therapy dysregulates iron transport and augments mitochondrial dysfunction in HIV-infected human microglia and neural-lineage cells","volume":"24","author":"Kaur","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.bbi.2026.106931_b0400","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2026.106931_b0405","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00281-022-00953-5","article-title":"Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection","volume":"44","author":"Killingsworth","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbi.2026.106931_b0410","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tips.2009.10.001","article-title":"The complexities of antiretroviral drug\u2013drug interactions: role of ABC and SLC transporters","volume":"31","author":"Kis","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0415","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","article-title":"Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy","volume":"14","author":"Ko","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0420","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae179","article-title":"Neuroinflammation generated by HIV-infected microglia promotes dysfunction and death of neurons in human brain organoids","volume":"3","author":"Kong","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.bbi.2026.106931_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02828","article-title":"The role of macrophages in HIV-1 persistence and pathogenesis","volume":"10","author":"Kruize","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbi.2026.106931_b0430","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13750","article-title":"Antiretroviral protease inhibitors induce features of cellular senescence that are reversible upon drug removal","volume":"22","author":"Kuehnemann","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbi.2026.106931_b0435","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS neurotoxicity of antiretrovirals","volume":"16","author":"Lanman","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1459877","article-title":"Exposure to the antiretroviral drug dolutegravir impairs structure and neurogenesis in a forebrain organoid model of human embryonic cortical development","volume":"17","author":"LaNoce","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0445","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbi.2024.11.031","article-title":"Central and peripheral kynurenine pathway metabolites in COVID-19: Implications for neurological and immunological responses","volume":"124","author":"Li","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106931_b0450","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/ph16121661","article-title":"The influence of nucleoside reverse transcriptase inhibitors on mitochondrial activity, lipid content, and fatty-acid-binding protein levels in microglial HMC3 cells","volume":"16","author":"Lipke","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bbi.2026.106931_b0455","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/ph14121221","article-title":"Contribution of mitochondrial dysfunction combined with NLRP3 inflammasome activation in selected neurodegenerative diseases","volume":"14","author":"Litwiniuk","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bbi.2026.106931_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci6030023","article-title":"Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders","volume":"6","author":"Liu","year":"2016","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008381","article-title":"HIV infects astrocytes in vivo and egresses from the brain to the periphery","volume":"16","author":"Lutgen","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbi.2026.106931_b0470","doi-asserted-by":"crossref","first-page":"285","DOI":"10.35772\/ghm.2024.01049","article-title":"State of the ART (antiretroviral therapy): long-acting HIV-1 therapeutics","volume":"6","author":"Ravichandran","year":"2024","journal-title":"Glob Health Med"},{"key":"10.1016\/j.bbi.2026.106931_b0475","doi-asserted-by":"crossref","unstructured":"Ma, Q., Vaida, F., Wong, J., Sanders, C.A., Kao, Y., Croteau, D., Clifford, D.B., Collier, A.C., Gelman, B.B., Marra, C.M., McArthur, J.C., Morgello, S., Simpson, D.M., Heaton, R.K., Grant, I., Letendre, S.L., CHARTER Group, 2016. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol 22, 170\u2013178. https:\/\/doi.org\/10.1007\/s13365-015-0382-7.","DOI":"10.1007\/s13365-015-0382-7"},{"key":"10.1016\/j.bbi.2026.106931_b0480","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0485","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","article-title":"HIV-1 Viral Protein R Activates NLRP3 Inflammasome in Microglia: implications for HIV-1 Associated Neuroinflammation","volume":"12","author":"Mamik","year":"2017","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0490","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cell.2020.03.005","article-title":"Curing HIV: seeking to target and clear persistent infection","volume":"181","author":"Margolis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2026.106931_b0495","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1007\/s00018-020-03561-4","article-title":"Functional impact of HIV-1 tat on cells of the CNS and its role in HAND","volume":"77","author":"Marino","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0500","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1093\/cid\/ciac658","article-title":"Declining prevalence of human immunodeficiency virus (HIV)\u2013associated neurocognitive disorders in recent years and associated factors in a large cohort of antiretroviral therapy\u2013treated individuals with HIV","volume":"76","author":"Mastrorosa","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0505","article-title":"Impact of switching to injectables cabotegravir and rilpivirine on sleep disturbances in a cohort of people living with HIV","volume":"25","author":"Mazzitelli","year":"2024","journal-title":"HIV Res. Clin. Pract."},{"key":"10.1016\/j.bbi.2026.106931_b0510","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1369757","article-title":"Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture","volume":"15","author":"McMullan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0515","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1186\/s12889-023-15935-x","article-title":"Prevalence and variability of HIV\/AIDS-associated neurocognitive impairments in Africa: a systematic review and meta-analysis","volume":"23","author":"Mekuriaw","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbi.2026.106931_b0520","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","article-title":"Update and latest advances in antiretroviral therapy","volume":"43","author":"Men\u00e9ndez-Arias","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0525","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/CPJ.0000000000200063","article-title":"Need to revise frascati criteria for HIV-associated neurocognitive disorders to improve relevance for diverse global populations","volume":"12","author":"Meyer","year":"2022","journal-title":"Neurology Clinical Practice"},{"key":"10.1016\/j.bbi.2026.106931_b0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2022.07.008","article-title":"Inflammasomes as mediators of inflammation in HIV-1 infection","volume":"252","author":"Min","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.bbi.2026.106931_b0535","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01595-23","article-title":"HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model","volume":"97","author":"Min","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2026.106931_b0540","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/cells10061548","article-title":"Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Mithaiwala","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0545","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/v15122385","article-title":"Is the central nervous system reservoir a hurdle for an HIV cure?","volume":"15","author":"Mohammadzadeh","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbi.2026.106931_b0550","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/cimb47050367","article-title":"Mechanisms of immune evasion in HIV-1: the role of virus-host protein interactions","volume":"47","author":"Mouzakis","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbi.2026.106931_b0555","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/cells14010054","article-title":"From homeostasis to neuroinflammation: insights into cellular and molecular interactions and network dynamics","volume":"14","author":"M\u00fcller","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0560","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.3390\/ijms252011170","article-title":"HIV-Associated neurocognitive disorder (HAND) and Alzheimer\u2019s disease pathogenesis: future directions for diagnosis and treatment","volume":"25","author":"Mustafa","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0565","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S2352-3018(23)00051-6","article-title":"Long-acting antiretrovirals and HIV treatment adherence","volume":"10","author":"Nachega","year":"2023","journal-title":"Lancet HIV"},{"key":"10.1016\/j.bbi.2026.106931_b0570","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12974-025-03353-2","article-title":"Inflammatory responses revealed through HIV infection of microglia-containing cerebral organoids","volume":"22","author":"Narasipura","year":"2025","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106931_b0575","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s13365-016-0448-1","article-title":"Discordant CSF\/plasma HIV-1 RNA in patients with unexplained low-level viraemia","volume":"22","author":"Nightingale","year":"2016","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.bbi.2026.106931_b0580","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","article-title":"Controversies in HIV-associated neurocognitive disorders","volume":"13","author":"Nightingale","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2026.106931_b0585","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.3390\/ijms26189069","article-title":"Microglial dysfunction and amyloid-beta pathology in Alzheimer\u2019s disease and HIV-associated neurocognitive disorders","volume":"26","author":"Njoku","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0590","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/JLB.5VMR0122-046RRR","article-title":"Shock and kill within the CNS: a promising HIV eradication approach?","volume":"112","author":"N\u00fchn","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2026.106931_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/v17040467","article-title":"Microglia exhibit a unique intact HIV reservoir in human postmortem brain tissue","volume":"17","author":"Nuhn","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.bbi.2026.106931_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2587094","article-title":"Pharmacokinetic, pharmacogenetic, and other factors influencing CNS Penetration of antiretrovirals","volume":"2016","author":"Nwogu","year":"2016","journal-title":"AIDS Research and Treatment"},{"key":"10.1016\/j.bbi.2026.106931_b0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063027","article-title":"Microglia diversity in healthy and diseased brain: insights from single-cell omics","volume":"22","author":"Ochocka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0610","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The Paradox of HIV Blood\u2013Brain Barrier Penetrance and Antiretroviral Drug delivery Deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0615","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1097\/QAD.0000000000003108","article-title":"Optimizing switching strategies to simplify antiretroviral therapy: the future of second-line from a public health perspective","volume":"35","author":"Papot","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0620","doi-asserted-by":"crossref","unstructured":"Payne, B., Chadwick, T.J., Blamire, A., Anderson, K.N., Parikh, J., Qian, J., Hynes, A.M., Wilkinson, J., Price, D.A., Efficacy of Switch to Lopinavir\/Ritonavir in Improving Cognitive Function in Efavirenz-treated Patients (SLICE) study team, 2017. Does efavirenz replacement improve neurological function in treated HIV infection? HIV Med 18, 690\u2013695. https:\/\/doi.org\/10.1111\/hiv.12503.","DOI":"10.1111\/hiv.12503"},{"key":"10.1016\/j.bbi.2026.106931_b0625","volume":"107825","author":"Perez-Valero","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bbi.2026.106931_b0630","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbi.2019.03.011","article-title":"HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NF\u03baB signaling axis","volume":"80","author":"Periyasamy","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106931_b0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1624770","article-title":"NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease","volume":"16","author":"Pinz\u00f3n-Fern\u00e1ndez","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2026.106931_b0640","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/glia.23568","article-title":"Human immunodeficiency virus Type-1 single-stranded RNA activates the NLRP3 inflammasome and impairs autophagic clearance of damaged mitochondria in human microglia","volume":"67","author":"Rawat","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2026.106931_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112110","article-title":"Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains","volume":"42","author":"Rheinberger","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0650","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2026.106931_b0655","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofag210","article-title":"Neuropsychiatric tolerability of long-acting cabotegravir and rilpivirine in people with HIV with prior INSTI-related CNS toxicity: a real-world cohort study","volume":"13","author":"Rosas Cancio-Su\u00e1rez","year":"2026","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0660","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fnmol.2017.00451","article-title":"Astroglial glutamate signaling and uptake in the hippocampus","volume":"10","author":"Rose","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2026.106931_b0665","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/glia.24033","article-title":"HIV-induced neuroinflammation inhibits oligodendrocyte maturation via glutamate-dependent activation of the PERK arm of the integrated stress response","volume":"69","author":"Roth","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2026.106931_b0670","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/pathogens12010092","article-title":"Role of TLRs in HIV-1 infection and potential of TLR agonists in HIV-1 vaccine development and treatment strategies","volume":"12","author":"Rozman","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.bbi.2026.106931_b0675","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biom12070894","article-title":"Pitfalls of antiretroviral therapy: current status and long-term CNS toxicity","volume":"12","author":"Rudd","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbi.2026.106931_b0680","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.celrep.2017.01.027","article-title":"Astrocytes resist HIV-1 fusion but engulf infected macrophage material","volume":"18","author":"Russell","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbi.2026.106931_b0685","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12974-024-03296-0","article-title":"Fueling neurodegeneration: metabolic insights into microglia functions","volume":"21","author":"Sadeghdoust","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106931_b0690","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/v17040572","article-title":"Neuroinflammation, blood\u2013brain barrier, and HIV reservoirs in the CNS: an in-depth exploration of latency mechanisms and emerging therapeutic strategies","volume":"17","author":"Said","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.bbi.2026.106931_b0695","doi-asserted-by":"crossref","first-page":"512","DOI":"10.18683\/germs.2021.1286","article-title":"Treatment initiation or switch to BIC\/FTC\/TAF - real-world safety and efficacy data from two HIV centers in Romania","volume":"11","author":"S\u0103ndulescu","year":"2021","journal-title":"Germs"},{"key":"10.1016\/j.bbi.2026.106931_b0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070201","article-title":"Virological efficacy in cerebrospinal fluid and neurocognitive status in patients with long-term monotherapy based on lopinavir\/ritonavir: an exploratory study","volume":"8","author":"Santos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106931_b0705","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12974-024-03124-5","article-title":"Extracellular vesicles produced by HIV-1 Nef-expressing cells induce myelin impairment and oligodendrocyte damage in the mouse central nervous system","volume":"21","author":"Schenck","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2026.106931_b0710","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2026.106931_b0715","doi-asserted-by":"crossref","unstructured":"Schweinsburg, B.C., Taylor, M.J., Alhassoon, O.M., Gonzalez, R., Brown, G.G., Ellis, R.J., Letendre, S., Videen, J.S., McCutchan, J.A., Patterson, T.L., Grant, I., The Hnrc Group, 2005. Brain mitochondrial injury in human immunodeficiency virus\u2013seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J Neurovirol 11, 356\u2013364. https:\/\/doi.org\/10.1080\/13550280591002342.","DOI":"10.1080\/13550280591002342"},{"key":"10.1016\/j.bbi.2026.106931_b0720","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/clim.2000.4905","article-title":"Activation of human microglial cells by HIV-1 gp41 and tat proteins","volume":"96","author":"Sheng","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbi.2026.106931_b0725","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3390\/cells9081857","article-title":"Role of inflammasomes in HIV-1 and drug abuse mediated neuroinflammaging","volume":"9","author":"Sil","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bbi.2026.106931_b0730","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","article-title":"Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance","volume":"129","author":"Spudich","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2026.106931_b0735","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1128\/JVI.02618-07","article-title":"Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious r5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin t1 in response to stimulation by lipopolysaccharides","volume":"82","author":"Sun","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2026.106931_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110136","article-title":"HIV1 gp120 activates microglia via TLR2-nf-\u03bab signaling to up-regulate inflammatory cytokine expression and induce neuropathic pain","volume":"260","author":"Sun","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2026.106931_b0745","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMoa1904398","article-title":"Long-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression","volume":"382","author":"Swindells","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2026.106931_b0750","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167417","article-title":"Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy","volume":"133","author":"Tang","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbi.2026.106931_b0755","first-page":"255","article-title":"Astrocyte dysfunctions and HIV-1 neurotoxicity","volume":"4","author":"Ton","year":"2013","journal-title":"J AIDS Clin Res"},{"key":"10.1016\/j.bbi.2026.106931_b0760","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1124\/jpet.112.195701","article-title":"Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz","volume":"343","author":"Tovar-y-Romo","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2026.106931_b0765","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3390\/ijms27052192","article-title":"HIV infection, neurotoxicity, inflammation, premature aging, and therapeutic challenges to PLWH: an overview","volume":"27","author":"Tyagi","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2026.106931_b0770","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","article-title":"Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?","volume":"29","author":"Underwood","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0775","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/jnc.15336","article-title":"Astrocytes are HIV reservoirs in the brain: a cell type with poor HIV infectivity and replication but efficient cell-to-cell viral transfer","volume":"158","author":"Valdebenito","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2026.106931_b0780","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179855","article-title":"CD14+CD16+ monocyte transmigration across the blood-brain barrier is associated with HIV-NCI despite viral suppression","volume":"9","author":"Veksler","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbi.2026.106931_b0785","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-023-01628-9","article-title":"Astrocytes in human central nervous system diseases: a frontier for new therapies","volume":"8","author":"Verkhratsky","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbi.2026.106931_b0790","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1016\/S2352-3018(23)00176-5","article-title":"Realising long-acting ART as first-line treatment","volume":"10","author":"Vijayan","year":"2023","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.bbi.2026.106931_b0795","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000000955","article-title":"HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance","volume":"30","author":"Vivithanaporn","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.bbi.2026.106931_b0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-023-00616-9","article-title":"HIV infection of non-classical cells in the brain","volume":"20","author":"Wahl","year":"2023","journal-title":"Retrovirology"},{"key":"10.1016\/j.bbi.2026.106931_b0805","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/JLB.5VMR0322-161R","article-title":"Animal models for studies of HIV-1 brain reservoirs","volume":"112","author":"Waight","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2026.106931_b0810","doi-asserted-by":"crossref","first-page":"e01941","DOI":"10.1128\/aac.01941-21","article-title":"Anti-HIV drugs cause mitochondrial dysfunction in monocyte-derived macrophages","volume":"66","author":"Wallace","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2026.106931_b0815","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","article-title":"Microglial cells: the main HIV-1 reservoir in the brain","volume":"9","author":"Wallet","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbi.2026.106931_b0820","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.2147\/DDDT.S520724","article-title":"Dolutegravir derivatives alleviate LPS-induced microglial inflammation by suppressing STAT1\/3 nuclear translocation","volume":"19","author":"Wang","year":"2025","journal-title":"DDDT"},{"key":"10.1016\/j.bbi.2026.106931_b0825","doi-asserted-by":"crossref","first-page":"e2507","DOI":"10.1371\/journal.pone.0002507","article-title":"Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk","volume":"3","author":"Wang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106931_b0830","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.581346","article-title":"The prevalence of frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbi.2026.106931_b0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069270","article-title":"Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106931_b0840","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1186\/s12879-023-08495-3","article-title":"Viral protein R (Vpr)-induced neuroinflammation and its potential contribution to neuronal dysfunction: a scoping review","volume":"23","author":"Williams","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0845","doi-asserted-by":"crossref","first-page":"152","DOI":"10.14336\/AD.2022.0712","article-title":"HIV Nef expression down-modulated GFAP expression and altered glutamate uptake and release and proliferation in astrocytes","volume":"14","author":"Wilson","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbi.2026.106931_b0850","doi-asserted-by":"crossref","unstructured":"Winston, A., Spudich, S., 2020. Cognitive disorders in people living with HIV. The Lancet HIV 7, e504\u2013e513. https:\/\/doi.org\/10.1016\/S2352-3018(20)30107-7.","DOI":"10.1016\/S2352-3018(20)30107-7"},{"key":"10.1016\/j.bbi.2026.106931_b0855","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00957-22","article-title":"Characterization of macrophage-tropic HIV-1 infection of central nervous system cells and the influence of inflammation","volume":"96","author":"Woodburn","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2026.106931_b0860","unstructured":"World Health Organization, 2025. HIV statistics, globally and by WHO region, 2025. World Health Organization."},{"key":"10.1016\/j.bbi.2026.106931_b0865","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s11481-020-09964-1","article-title":"Emerging role of Nef in the development of HIV associated neurological disorders","volume":"16","author":"Yarandi","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2026.106931_b0870","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bbi.2020.04.016","article-title":"Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression","volume":"88","author":"Zhang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106931_b0875","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.bbi.2026.106931_b0880","article-title":"Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106931_b0885","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/ijms24031994","article-title":"Cabotegravir Exposure of Zebrafish (Danio rerio) Embryos Impacts on Neurodevelopment and Behavior","volume":"24","author":"Zizioli","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.bbi.2026.106931_b0890","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jnc.14668","article-title":"Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKII\u03b2-GSK3\u03b2 interactions","volume":"149","author":"Zou","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2026.106931_b0895","doi-asserted-by":"crossref","first-page":"11384","DOI":"10.1523\/JNEUROSCI.4740-14.2015","article-title":"Oligodendrocytes are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development","volume":"35","author":"Zou","year":"2015","journal-title":"J. Neurosci."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126006793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:31:58Z","timestamp":1791653518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126006793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":177,"alternative-id":["S0889159126006793"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106931","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimmune crosstalk in HIV-associated neurocognitive disorders and the impact of antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}